Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4869539
Max Phase: Preclinical
Molecular Formula: C20H9FO8
Molecular Weight: 396.28
Molecule Type: Unknown
Associated Items:
ID: ALA4869539
Max Phase: Preclinical
Molecular Formula: C20H9FO8
Molecular Weight: 396.28
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12
Standard InChI: InChI=1S/C20H9FO8/c21-10-3-1-2-8(4-10)11-5-9-6-13(17(22)23)19(26)28-15(9)12-7-14(18(24)25)20(27)29-16(11)12/h1-7H,(H,22,23)(H,24,25)
Standard InChI Key: ZRPABDXNNFWTFU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 396.28 | Molecular Weight (Monoisotopic): 396.0281 | AlogP: 3.10 | #Rotatable Bonds: 3 |
Polar Surface Area: 135.02 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 2.61 | CX Basic pKa: | CX LogP: 2.56 | CX LogD: -4.39 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.40 | Np Likeness Score: -0.16 |
1. Wei L, Hou T, Li J, Zhang X, Zhou H, Wang Z, Cheng J, Xiang K, Wang J, Zhao Y, Liang X.. (2021) Structure-Activity Relationship Studies of Coumarin-like Diacid Derivatives as Human G Protein-Coupled Receptor-35 (hGPR35) Agonists and a Consequent New Design Principle., 64 (5.0): [PMID:33630609] [10.1021/acs.jmedchem.0c01624] |
Source(1):